Position in RDNT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,184,925
+$1,305,801 QoQ
Shares Held
116,506
+10.8% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#85
of 328 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $17,367,922 across 10 Diagnostics & Research names. RDNT ranks #1 (41.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDNT |
RadNet, Inc.
This page
|
116,506 | $7,184,925 | |
| 2 | NEO |
Neogenomics Inc
|
223,846 | $3,265,913 | |
| 3 | VCYT |
Veracyte, Inc.
|
52,337 | $3,073,752 | |
| 4 | DGX |
Quest Diagnostics Inc
|
4,281 | $907,357 | |
| 5 | CSTL |
Castle Biosciences Inc
|
31,748 | $757,189 | |
| 6 | GRAL |
GRAIL, Inc.
|
8,696 | $593,675 | |
| 7 | MYGN |
Myriad Genetics Inc
|
97,375 | $556,011 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
2,831 | $547,005 |
All Filings in RDNT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,184,925 | 116,506 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $5,879,124 | 105,191 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $8,116,776 | 113,760 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $9,479,761 | 124,390 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $24,382,577 | 428,441 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $21,279,762 | 427,992 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $28,983,600 | 415,000 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $27,909,004 | 402,205 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $10,281,068 | 174,492 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,620,049 | 53,844 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||